Nasal Decongestant Tablet, Film Coated
Product Images NDC 41250-432

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Nasal Decongestant (NDC 41250-432). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meijer Distribution Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

432 6e Nasal Decongestant Image

432 6e Nasal Decongestant Image
Meijer distributes ON-DRO tablets containing Pseudoephedrine Hydrochloride with a strength of 30 mg. It temporarily relieves nasal congestion and associated symptoms from allergies or upper respiratory issues. However, it should not be used by people taking prescription medication for Parkinson's disease, depression, or emotional conditions unless approved by a doctor. It should also not be used in children under six years old. The product has other ingredients, including calcium carbonate and polyethylene glycol, but it is not advised to exceed more than eight tablets within 24 hours. Johnson & Johnson distributes this product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.